PACTR202007611764617尚未招募3 期
An Open-label Clinical Trial of Anti-viral Efficacy and Immune-boosting Effects of Oral Treatment with Black Seed Oil in Patients with Corona Virus Disease (COVID-19)
agos State Government0 个研究点目标入组 80 人开始时间: 2020年7月6日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •Individuals who have been tested and confirmed to be positive
- •Stable, not on ventilator
- •Not having any underlining ailment
- •males or females above 18 years.
排除标准
- •Individuals already tested negative
- •Known allergy to black seed oil,
- •Those that have had treatment with any drugs or any other medicine in the last 2 weeks,
- •Those who refused to give informed consent,
- •Those with hypertension, pregnancy, breastfeeding, diabetes, asthma, hepatitis, or any other ailments
- •Those participating in other studies at the Centre.
研究者
相似试验
进行中（未招募）
1 期
Investigation of the antiviral effect of Voclosporine on COVID-19 in renal transplant patientsSARS-CoV-2 infection in Kidney Transplant RecipientsMedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 21.1Level: LLTClassification code 10052212Term: Organ transplant NOSSystem Organ Class: 100000004865EUCTR2020-001467-82-NLeiden University Medical Center30
已完成
2 期
An Open-Label Study Evaluating Anti-Viral Effects of Voclosporin in SARS-CoV-2 Positive Kidney Transplant Recipients - the VOCOVID StudyNL-OMON55051eids Universitair Medisch Centrum20
进行中（未招募）
1 期
Phase 1/2 study of IMC-I109V in non-cirrhotic HBeAg-negative chronic HBV infectiochronic hepatitis B virus (HBV) infectionMedDRA version: 20.0Level: LLTClassification code 10019182Term: HBVSystem Organ Class: 100000004848MedDRA version: 20.0Level: LLTClassification code 10019743Term: Hepatitis B virus (HBV)System Organ Class: 100000004848EUCTR2019-004212-64-BEImmunocore Ltd108
招募中
1 期
Phase 1/2 study of IMC-I109V in non-cirrhotic HBeAg-negative chronic hepatitis B (HBV) infectioHBeAg-negative chronic HBV infectionInfection - Other infectious diseasesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12620000403932Immunocore Ltd80
进行中（未招募）
1 期
Phase 1/2 study of IMC-I109V in non-cirrhotic HBeAg-negative chronic HBV infectioEUCTR2019-004212-64-PLImmunocore Ltd80